Literature DB >> 20037587

Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.

Han-Xiang Deng1, Christopher J Klein, Jianhua Yan, Yong Shi, Yanhong Wu, Faisal Fecto, Hau-Jie Yau, Yi Yang, Hong Zhai, Nailah Siddique, E Tessa Hedley-Whyte, Robert Delong, Marco Martina, Peter J Dyck, Teepu Siddique.   

Abstract

Scapuloperoneal spinal muscular atrophy (SPSMA) and hereditary motor and sensory neuropathy type IIC (HMSN IIC, also known as HMSN2C or Charcot-Marie-Tooth disease type 2C (CMT2C)) are phenotypically heterogeneous disorders involving topographically distinct nerves and muscles. We originally described a large New England family of French-Canadian origin with SPSMA and an American family of English and Scottish descent with CMT2C. We mapped SPSMA and CMT2C risk loci to 12q24.1-q24.31 with an overlapping region between the two diseases. Further analysis reduced the CMT2C risk locus to a 4-Mb region. Here we report that SPSMA and CMT2C are allelic disorders caused by mutations in the gene encoding the transient receptor potential cation channel, subfamily V, member 4 (TRPV4). Functional analysis revealed that increased calcium channel activity is a distinct property of both SPSMA- and CMT2C-causing mutant proteins. Our findings link mutations in TRPV4 to altered calcium homeostasis and peripheral neuropathies, implying a pathogenic mechanism and possible options for therapy for these disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20037587      PMCID: PMC3786192          DOI: 10.1038/ng.509

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  31 in total

1.  OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity.

Authors:  R Strotmann; C Harteneck; K Nunnenmacher; G Schultz; T D Plant
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

2.  OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum.

Authors:  Yan Wang; Xiao Fu; Stephanie Gaiser; Michael Köttgen; Albrecht Kramer-Zucker; Gerd Walz; Tomasz Wegierski
Journal:  J Biol Chem       Date:  2007-10-11       Impact factor: 5.157

3.  Structural analyses of the ankyrin repeat domain of TRPV6 and related TRPV ion channels.

Authors:  Christopher B Phelps; Robert J Huang; Polina V Lishko; Ruiqi R Wang; Rachelle Gaudet
Journal:  Biochemistry       Date:  2008-01-31       Impact factor: 3.162

4.  Stimulus-specific modulation of the cation channel TRPV4 by PACSIN 3.

Authors:  Dieter D'hoedt; Grzegorz Owsianik; Jean Prenen; Math Pham Cuajungco; Christian Grimm; Stefan Heller; Thomas Voets; Bernd Nilius
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

Review 5.  Transient receptor potential cation channels in disease.

Authors:  Bernd Nilius; Grzegorz Owsianik; Thomas Voets; John A Peters
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 6.  Molecular mechanisms of TRPV4-mediated neural signaling.

Authors:  Wolfgang Liedtke
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

7.  Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia.

Authors:  Deborah Krakow; Joris Vriens; Natalia Camacho; Phi Luong; Hannah Deixler; Tara L Funari; Carlos A Bacino; Mira B Irons; Ingrid A Holm; Laurie Sadler; Ericka B Okenfuss; Annelies Janssens; Thomas Voets; David L Rimoin; Ralph S Lachman; Bernd Nilius; Daniel H Cohn
Journal:  Am J Hum Genet       Date:  2009-02-19       Impact factor: 11.025

8.  Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia.

Authors:  Matthew J Rock; Jean Prenen; Vincent A Funari; Tara L Funari; Barry Merriman; Stanley F Nelson; Ralph S Lachman; William R Wilcox; Soraya Reyno; Roberto Quadrelli; Alicia Vaglio; Grzegorz Owsianik; Annelies Janssens; Thomas Voets; Shiro Ikegawa; Toshiro Nagai; David L Rimoin; Bernd Nilius; Daniel H Cohn
Journal:  Nat Genet       Date:  2008-06-29       Impact factor: 38.330

9.  Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy.

Authors:  Juliane Ramser; Mary Ellen Ahearn; Claus Lenski; Kemal O Yariz; Heide Hellebrand; Michael von Rhein; Robin D Clark; Rita K Schmutzler; Peter Lichtner; Eric P Hoffman; Alfons Meindl; Lisa Baumbach-Reardon
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

10.  X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1.

Authors:  Catarina M Quinzii; Tuan H Vu; K Christopher Min; Kurenai Tanji; Sandra Barral; Raji P Grewal; Andrea Kattah; Pilir Camaño; David Otaegui; Teruhito Kunimatsu; David M Blake; Kirk C Wilhelmsen; Lewis P Rowland; Arthur P Hays; Eduardo Bonilla; Michio Hirano
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

View more
  93 in total

1.  TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice.

Authors:  Shaik O Rahaman; Lisa M Grove; Sailaja Paruchuri; Brian D Southern; Susamma Abraham; Kathryn A Niese; Rachel G Scheraga; Sudakshina Ghosh; Charles K Thodeti; David X Zhang; Magdalene M Moran; William P Schilling; Daniel J Tschumperlin; Mitchell A Olman
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

Review 2.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 3.  Inherited neuropathies: clinical overview and update.

Authors:  Christopher J Klein; Xiaohui Duan; Michael E Shy
Journal:  Muscle Nerve       Date:  2013-06-26       Impact factor: 3.217

Review 4.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

5.  Lysosomal Regulation of Inter-mitochondrial Contact Fate and Motility in Charcot-Marie-Tooth Type 2.

Authors:  Yvette C Wong; Wesley Peng; Dimitri Krainc
Journal:  Dev Cell       Date:  2019-06-20       Impact factor: 12.270

6.  TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies.

Authors:  C J Klein; Y Shi; F Fecto; M Donaghy; G Nicholson; M E McEntagart; A H Crosby; Y Wu; H Lou; K M McEvoy; T Siddique; H-X Deng; P J Dyck
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

7.  Autosomal dominant late-onset spinal motor neuronopathy is linked to a new locus on chromosome 22q11.2-q13.2.

Authors:  Sini Penttilä; Manu Jokela; Peter Hackman; Anna Maija Saukkonen; Jari Toivanen; Bjarne Udd
Journal:  Eur J Hum Genet       Date:  2012-04-25       Impact factor: 4.246

Review 8.  [Genetics of neuropathies].

Authors:  B Gess; A Schirmacher; P Young
Journal:  Nervenarzt       Date:  2013-02       Impact factor: 1.214

Review 9.  Role of local vitamin D signaling and cellular calcium transport system in bone homeostasis.

Authors:  Ritsuko Masuyama
Journal:  J Bone Miner Metab       Date:  2013-11-09       Impact factor: 2.626

10.  Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.

Authors:  Alexander M Rossor; Emily C Oates; Hannah K Salter; Yang Liu; Sinead M Murphy; Rebecca Schule; Michael A Gonzalez; Mariacristina Scoto; Rahul Phadke; Caroline A Sewry; Henry Houlden; Albena Jordanova; Iyailo Tournev; Teodora Chamova; Ivan Litvinenko; Stephan Zuchner; David N Herrmann; Julian Blake; Janet E Sowden; Gyuda Acsadi; Michael L Rodriguez; Manoj P Menezes; Nigel F Clarke; Michaela Auer Grumbach; Simon L Bullock; Francesco Muntoni; Mary M Reilly; Kathryn N North
Journal:  Brain       Date:  2014-12-14       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.